Study to Investigate the Health Benefits of a Quercetin/Curcumin-Based Supplement for Mild to Moderate Long COVID-19 Symptoms

NARecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 22, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Long COVID
Interventions
DIETARY_SUPPLEMENT

Nasafytol® (Quercetin/Curcumin Supplement)

Participants in this group will receive Nasafytol®, a combined dietary supplement containing quercetin (65 mg) and curcumin (42 mg). Participants will take two capsules (single administration) twice a day for a duration of 8 weeks. The supplement is intended to alleviate mild to moderate symptoms of Long COVID-19, including but not limited to fatigue, cognitive function, generalized body pain, low mood, sleep disturbance, and overall quality of life.

Trial Locations (1)

76090

RECRUITING

Liaquat University of Medical & Health Sciences (LUMHS), Jamshoro

All Listed Sponsors
lead

Liaquat University of Medical & Health Sciences

OTHER

NCT06974058 - Study to Investigate the Health Benefits of a Quercetin/Curcumin-Based Supplement for Mild to Moderate Long COVID-19 Symptoms | Biotech Hunter | Biotech Hunter